Universe Pharmaceuticals INC Increase (Decrease) in Accounts Payable
Universe Pharmaceuticals INC (UPC) reported Increase (Decrease) in Accounts Payable of -$3.13 billion for the 12-month period ending 2025-09-30, per its 20-F filed 2026-01-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-01-29
| Period end | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|
| 2025-09-30 | -$3.13B 20-F · filed 2026-01-29 | ||
| 2024-09-30 | $143.75M 20-F · filed 2026-01-29 | $143.75K 20-F · filed 2025-04-29 | |
| 2024-03-31 | $3.14M 6-K · filed 2024-09-20 | ||
| 2023-09-30 | $1.64B 20-F · filed 2026-01-29 | $1.64M 20-F · filed 2024-01-30 | |
| 2023-03-31 | $7.93M 6-K · filed 2024-09-20 | ||
| 2022-09-30 | -$1.92M 20-F · filed 2025-04-29 | -$1.90M 20-F · filed 2023-02-10 | |
| 2022-03-31 | -$1.75M 6-K · filed 2023-08-31 | ||
| 2021-09-30 | $2.46M 20-F · filed 2024-01-30 | ||
| 2021-03-31 | $5.80M 6-K · filed 2022-08-16 | ||
| 2020-09-30 | $639.43K 20-F · filed 2023-02-10 | ||
| 2019-09-30 | -$924.44K 20-F · filed 2022-01-31 |